Prevalence of post-COVID syndrome in students from ICBI, UAEH (2022)
Abstract
After suffering the COVID-19 disease, some patients may present persistent clinical manifestations, such as pulmonary, cardiac, neurological, among others. These remain for several weeks not explained by other diagnoses, but as a sequel of the same disease, a condition called post-COVID syndrome. There is little information on this subject because patients recover from the acute disease, and generally there is no medical follow-up. This work explored the student population from ICBI, UAEH, at the time of the fifth wave of the disease in Mexico, to measure the prevalence of post-COVID syndrome in 78 confirmed patients, after 12 weeks of recovery from the acute phase. 53.3% showed at least one of the symptoms. The prevalence of the disease in the student population from ICBI is 1.04%. In addition, cognitive impairment was measured in 19 of the patients. All of them showed memory failures, ranging from mild to severe, mainly in regular daily activities.
Downloads
References
Aragón-Nogales, R., Vargas-Almanza, I., Miranda-Novales, M.G. (2019). COVID-19 por SARS-Cov-2: la nueva emergencia de salud. Revista Mexicana de Pediatría, 86 (6), 213-218. Epub 03 de diciembre de 2020. Recuperado el 03 de noviembre de 2023, http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0035-00522019000600213&lng=es&tlng=es.
Bombón-Albán P. E. (2021). Síndrome COVID prolongado asociado a niebla cerebral. Neurología Argentina 13(4), 262–264. https://doi.org/10.1016/j.neuarg.2021.06.002
Bouza, E., Cantón Moreno, R., De Lucas Ramos, P., García-Botella, A., García-Lledó, A., Gómez-Pavón, J., González del Castillo, J., Hernández-Sampelayo, T., Martín-Delgado, M. C., Martín Sánchez, F. J., Martínez-Sellés, M., Molero García, J. M., Moreno Guillén, S., Rodríguez-Artalejo, F. J., Ruiz-Galiana, J., De Pablo Brühlmann, S., Porta Etessam, J., Santos Sebastián, M. (2021). Síndrome post-COVID: Un documento de reflexión y opinión [Post-COVID syndrome: A reflection and opinion paper]. Revista Española de Quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, 34(4), 269–279. https://doi.org/10.37201/req/023.2021
Cai, J., Lin, K., Zhang, H., Xue, Q., Zhu, K., Yuan, G., Sun, Y., Zhu, F., Ai, J., Wang, S., Zhang, W. (2023). A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerging Microbes & Infections 12(2), 2220578. https://doi.org/10.1080/22221751.2023.2220578
Carod-Artal, F. J. (2021). Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Revista de Neurología, 72(11), 384–396. https://doi.org/10.33588/RN.7211.2021230
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., Akrami, A. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. E Clinical Medicine 38, 101019. https://doi.org/10.1016/j.eclinm.2021.101019
Díaz-Quiñónez, J. A. (2021). Vacunas contra la COVID-19 y aparición de variantes del SARS-CoV-2. Reflexionando sobre el caso de México. Gaceta Médica de México, 157(2), 125–126. https://doi.org/10.24875/GMM.M21000499
Fajardo Dolci, G., Chavolla Magaña, R., Chavolla González, R. (2022) Anosmia. In: Halabe Cherem, J., Robledo Aburto, Z., Fajardo Dolci, G. (Eds.), Síndrome post-COVID-19. Certezas e interrogantes. Editorial Médica Panamericana, Buenos Aires. pp. 19-27.
FDA (2021). La FDA aprueba la primera vacuna contra la COVID-19. U. S. Food and Drug Administration. Recuperado el 8 de noviembre, 2022, https://www.fda.gov/news-events/press-announcements/la-fda-aprueba-la-primera-vacuna-contra-el-covid-19
Fernández-de-las-Peñas, C., Palacios-Ceña, D., Gómez-Mayordomo, V., Palacios-Ceña, M., Rodríguez-Jiménez, J., de-la-Llave-Rincón, A. I., Velasco-Arribas, M., Fuensalida-Novo, S., Ambite-Quesada, S., Guijarro, C., Cuadrado, M. L., Florencio, L. L., Arias-Navalón, J. A., Ortega-Santiago, R., Elvira-Martínez, C. M., Molina-Trigueros, L. J., Torres-Macho, J., Sebastián-Viana, T., Canto-Diez, M. G., Cigarán-Méndez, M., Arendt-Nielsen, L. (2022). Fatigue and dyspnoea as main persistent post-COVID-19 symptoms in previously hospitalized patients: related functional limitations and disability. Respiration 101(2), 132–141. https://doi.org/10.1159/000518854
Ferreira, J. C., Moreira, T. C. L., de Araújo, A. L., Imamura, M., Damiano, R. F., Garcia, M. L., Sawamura, M. V., Pinna, F. R., Guedes, B. F., Gonçalves, F. A. R., Mancini, M., Burdmann, E. A., da Silva Filho, D. F., Polizel, J. L., Bento, R. F., Rocha, V., Nitrini, R., de Souza, H. P., Levin, A. S., Kallas, E. G., Forlenza, O. V., Busatto, G. F., Batistella, L. R., Ribeiro de Carvalho, C. R., Mauad, T., Gouveia, N. (2022). Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. Journal of Global Health 12, 05029. https://doi.org/10.7189/jogh.12.05029
Flores Rivera, J. J. (2022). Meningitis y Encefalitis In: Halabe Cherem, J., Robledo Aburto, Z., Fajardo Dolci, G. (Eds.), Síndrome post-COVID-19. Certezas e interrogantes. Editorial Médica Panamericana, Buenos Aires. pp. 15-18.
Guo, P., Benito Ballesteros, A., Yeung, S. P., Liu, R., Saha, A., Curtis, L., Kaser, M., Haggard, M. P., Cheke, L. G. (2022). COVCOG 1: Factors predicting physical, neurological and cognitive symptoms in long COVID in a community sample. A first publication from the COVID and cognition study. Frontiers in Aging Neuroscience 14, 804922. https://doi.org/10.3389/fnagi.2022.804922
Gutiérrez Robledo, J. J. (2022). El paciente geriátrico In: Halabe Cherem, J., Robledo Aburto, Z., Fajardo Dolci, G. (Eds.), Síndrome post-COVID-19. Certezas e interrogantes. Editorial Médica Panamericana, Buenos Aires. pp. 207-215.
Mahboubi Mehrabani, M., Karvandi, M. S., Maafi, P., Doroudian, M. (2022). Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Reviews in Medical Virology 32(6), e2334. https://doi.org/10.1002/rmv.2334
OMS (2020). Cronología de la respuesta de la OMS a la COVID-19. Organización Mundial de la Salud. Recuperado el 8 de noviembre, 2022, https://www.who.int/es/news/item/29-06-2020-covidtimeline
OMS (2021). Clasificación de la variante ómicron (B.1.1.529) del SARS-CoV-2 como variante preocupante. Organización Mundial de la Salud. Recuperado el 8 de noviembre de 2022, https://www.who.int/es/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
OMS (2022). COVAX: colaboración para un acceso equitativo mundial a las vacunas contra la COVID-19 Recuperado el 8 de noviembre, 2022, https://www.who.int/es/initiatives/act-accelerator/covax
ONS (2023). Prevalence of ongoing symptoms following coronavirus (COVID 19) infection in the UK: 2 february 2023. Office for National Statistics, UK. Recuperado el 5 de noviembre de 2023, https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023
Salado Burbano, J. C., Pacheco Sánchez A. V., Halabe Cherem, J. (2022). Fatiga crónica. In: Halabe Cherem, J., Robledo Aburto, Z., Fajardo Dolci, G. (Eds.), Síndrome post-COVID-19. Certezas e interrogantes. Editorial Médica Panamericana, Buenos Aires. pp. 237-244.
Suárez, V., Suarez Quezada, M., Oros Ruiz, S., Ronquillo de Jesús, E. (2020). Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Revista Clínica Española, 220(8), 463. https://doi.org/10.1016/J.RCE.2020.05.007
Tajer, C., Martínez, M. J., Mariani, J., De Abreu, M., Antonietti, L. (2023). Síndrome post COVID-19. Gravedad y evolución en 4673 trabajadores sanitarios. Medicina 83(5), 669–682.
WHO (2020). Pneumonia of unknown cause. World Health Organization. Recuperado el 8 de Noviembre 2022, https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON22
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F. Phil, D., Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 382, 727-733. https://www.nejm.org/doi/full/10.1056/NEJMoa2001017
Copyright (c) 2024 Estefanía Gress Hernández, Ulises Iturbe Acosta
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
